Transplant Diagnostics Market by Molecular and Non-Molecular Assay Technology (Serological assay, Mixed Lymphocyte Culture, PCR Based, Sequencing Based), End-User (Hospitals and transplant centers, Research laboratories and academic institutes, Commercial Service Providers) Global Opportunity Analysis and Industry Forecast, 2014-2022
Transplant diagnostics are tests that are performed pre and post-transplant procedures to check the compatibility between the donor and recipient of organ and its suitability in the body. It is mainly required to reduce the risk of organ rejection that can take place due to incompatible donors. Post-transplant, series of diagnostics tests are performed to check the chances of organ rejection.
Browse the full report @ http://www.orbisresearch.com/reports/index/transplant-diagnostics-market-by-molecular-and-non-molecular-assay-technology-end-user-global-opportunity-analysis-and-industry-forecast-2014-2022 .
The world transplant diagnostics market is projected to reach $1,031 million by 2022 and this growth is fueled by factors such as increasing elderly population, increased incidences of chronic disease patients, and increased focus on R&D. The market for transplant diagnostics is flanked with technological progression that is stimulated by increasing awareness related importance of organ donations. Although these factors will drive the market for transplant diagnostics there are certain elements that can limit the growth of the market. Worldwide scenario for organ shortage and difficulties in HLA sequencing can restrict the growth of the market.
Check the DISCOUNT on this report @ http://www.orbisresearch.com/contacts/discount/223542 .
The transplant diagnostics market is segmented on the basis of technology, components, application, end-users, type of organ, type of screening, and geography. The world transplant diagnostics market based on the technology is segmented into non-molecular assay and molecular assay technologies. The non-molecular assay technologies are further categorized as serological assay and Mixed Lymphocyte Culture (MLC) assay. The molecular assay technology is categorized into PCR-based and sequencing based. The global transplant diagnostics market based on the components is classified into instruments, reagents and consumables, and software and services. The transplant diagnostics market based on end-user is categorized as hospitals and transplant centers, research laboratories and academic institutes, and commercial service provider. On the bases of applications, the transplant diagnostics market is broadly classified into research and diagnostics. Further the market based on the type of organ is segmented into kidney, liver, heart, lung, pancreas, and others. On the bases of type of screening the market is categorized into pre-transplant screening and post-transplant screening. By geography the market is divided into North America, Europe, Asia Pacific and ROW including further segmentation of the major countries. The key players in the transplant diagnostics market are focused on strategies such as product approval and launches, merger and acquisition, expansion, collaboration etc. to expand their market share.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/223542 .
For more information contact email@example.com
1 Immucor, Inc. (TPG Capital)
1.1 Company overview
1.2 Operating business segments
1.3 Business performance
1.4 Key strategic moves & developments
2 Bio-Rad Laboratories, Inc.
2.1 Company overview
2.2 Operating business segments
2.3 Business performance
2.4 Key strategic moves & developments
3 Thermo Fisher Scientific Inc.
3.1 Company overview
3.2 Operating business segments
3.3 Business performance
3.4 Key strategic moves & developments
4 F. Hoffmann-la Roche AG
4.1 Company overview
4.2 Operating business segments
4.3 Business performance
4.4 Key strategic moves & developments
5 Illumina, Inc.
5.1 Company overview
5.2 Operating business segments
5.3 Business performance
5.4 Key strategic moves & developments
6 Abbott Laboratories
6.1 Company overview
6.2 Operating business segments
6.3 Business performance
6.4 Key strategic moves & developments
7 Sigma-Aldrich Corporation
7.1 Company overview
7.2 Operating business segments
7.3 Business performance
8 Qiagen N.V.
8.1 Company overview
8.2 Operating business segments
8.3 Business performance
8.4 Key strategic moves & developments
9 Olerup SSP AB (Allenex)
9.1 Company overview
9.2 Key strategic moves & developments
10 DiaSorin S.P.A.
10.1 Company overview
10.2 Operating business segments
10.3 Business performance
10.4 Key strategic moves & developments
This report provides an extensive analysis of the current and emerging market trends and dynamics in the world transplant diagnostics market.
In-depth analysis has been done in this report by constructing market estimations for the key market segments between 2014 and 2022.
Comprehensive analysis of factors that drive and restrict the growth of the world transplant diagnostics market is provided.
Exhaustive analysis of the world transplant diagnostics market by technology helps in understanding the current range of the product available for commercial usage.
Competitive intelligence helps in understanding the competitive scenario across the geographies
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/223542 .
For any enquires before buying, connect with us @ firstname.lastname@example.org
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/OrbisResearch